We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Boston Omaha
BOC
$436M
| $1.48M | ﹤0.01% |
53,521
+9,239
| +21% | +$189K |
|
|
PCSB
2627
DELISTED
PCSB Financial Corporation
PCSB
| $1.48M | ﹤0.01% |
92,827
-11,758
| -11% | -$174K |
|
|
QTNT
2628
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.48M | ﹤0.01% |
7,098
+247
| +4% | +$57.5K |
|
|
BCLI
2629
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.48M | ﹤0.01% |
8,242
+1,136
| +16% | +$155K |
|
2630
NVE Corp
NVEC
$609M
| $1.48M | ﹤0.01% |
26,274
-28,020
| -52% | -$1.44M |
|
2631
CEL-SCI Corp
CVM
$30.1M
| $1.48M | ﹤0.01% |
4,214
-369
| -8% | -$146K |
|
2632
Pulse Biosciences
PLSE
$3.02B
| $1.47M | ﹤0.01% |
61,711
-5,620
| -8% | -$89.4K |
|
|
REVG
2633
DELISTED
REV Group
REVG
| $1.47M | ﹤0.01% |
167,067
+29,429
| +21% | +$262K |
|
2634
BeyondSpring
BYSI
$35.8M
| $1.47M | ﹤0.01% |
120,542
+87,179
| +261% | +$1.15M |
|
|
CBIO
2635
Crescent Biopharma
CBIO
$626M
| $1.47M | ﹤0.01% |
3,906
+483
| +14% | +$169K |
|
2636
Sierra Bancorp
BSRR
$525M
| $1.46M | ﹤0.01% |
61,125
+355
| +0.6% | +$7.61K |
|
|
AUD
2637
DELISTED
Audacy, Inc.
AUD
| $1.46M | ﹤0.01% |
589,414
-416,970
| -41% | -$852K |
|
2638
Puma Biotechnology
PBYI
$454M
| $1.45M | ﹤0.01% |
141,450
+267
| +0.2% | +$2.7K |
|
|
STFC
2639
DELISTED
State Auto Financial Corp
STFC
| $1.45M | ﹤0.01% |
81,651
-243
| -0.3% | -$3.69K |
|
2640
NN Inc
NNBR
$311M
| $1.44M | ﹤0.01% |
219,732
+21,415
| +11% | +$133K |
|
2641
Oppenheimer Holdings
OPY
$1.2B
| $1.44M | ﹤0.01% |
45,927
+4,696
| +11% | +$132K |
|
|
HT
2642
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.44M | ﹤0.01% |
182,523
-38,451
| -17% | -$262K |
|
2643
Capital City Bank Group
CCBG
$890M
| $1.44M | ﹤0.01% |
58,541
-292
| -0.5% | -$6.71K |
|
|
CUTR
2644
DELISTED
Cutera, Inc.
CUTR
| $1.44M | ﹤0.01% |
59,590
+381
| +0.6% | +$8.14K |
|
2645
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $1.43M | ﹤0.01% |
303,966
-29,834
| -9% | -$132K |
|
|
IVC
2646
DELISTED
Invacare Corporation
IVC
| $1.43M | ﹤0.01% |
159,642
+19,716
| +14% | +$164K |
|
|
EIGR
2647
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.42M | ﹤0.01% |
3,864
+655
| +20% | +$188K |
|
|
ORC
2648
Orchid Island Capital
ORC
$1.31B
| $1.42M | ﹤0.01% |
54,387
+117
| +0.2% | +$3.1K |
|
|
DEN
2649
DELISTED
Denbury Inc.
DEN
| $1.41M | ﹤0.01% |
54,998
| – | – |
|
|
PLYM
2650
DELISTED
Plymouth Industrial REIT
PLYM
| $1.41M | ﹤0.01% |
94,039
+23,246
| +33% | +$311K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.